Klinger Shannon Thyme
Chief Legal Officer
Klinger Shannon Thyme has filed 14 SEC Form 4 filings (96 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Sep 8, 2026.
On the most recent filing, Klinger Shannon Thyme is listed as Chief Legal Officer at Moderna, Inc. Inside the rolling window, Klinger Shannon Thyme reported no open-market purchases and 3 open-market sales totaling $1.4M in MRNA. The largest disclosed transaction in the window is a sale of 13,885 MRNA shares on Mar 2, 2026, worth $726K.
Companies traded
Other insiders at MRNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Klinger Shannon Thyme made?
Klinger Shannon Thyme has filed 14 SEC Form 4 filings (96 transaction rows) across 1 company since 2025.
Which companies does Klinger Shannon Thyme trade?
Klinger Shannon Thyme has filed SEC Form 4 disclosures for 1 company, including MRNA.
When was Klinger Shannon Thyme's most recent SEC Form 4 filing?
Klinger Shannon Thyme's most recent SEC Form 4 filing on Tracefour is dated Sep 8, 2026.
What is Klinger Shannon Thyme's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Klinger Shannon Thyme is listed as Chief Legal Officer.
What is Klinger Shannon Thyme's total buy and sell value in the current window?
Inside the rolling retention window, Klinger Shannon Thyme bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Klinger Shannon Thyme's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,885 MRNA shares on 2026-03-02, worth $726K, per SEC Form 4 filings.